Page last updated: 2024-11-01

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Lymphoma

n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Lymphoma in 2 studies

N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.

Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vogel, CF1
Li, W1
Sciullo, E1
Newman, J1
Hammock, B1
Reader, JR1
Tuscano, J1
Matsumura, F1
Papadimitriou, MN1
McIntire, LV1
Menter, DG1

Other Studies

2 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Lymphoma

ArticleYear
Pathogenesis of aryl hydrocarbon receptor-mediated development of lymphoma is associated with increased cyclooxygenase-2 expression.
    The American journal of pathology, 2007, Volume: 171, Issue:5

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Environmental P

2007
Effect of cyclooxygenase inhibitors in the adhesion of tumor cells to endothelial cells.
    Critical reviews in biomedical engineering, 2000, Volume: 28, Issue:1-2

    Topics: Animals; Cell Adhesion; Cyclooxygenase Inhibitors; Endothelium; Indomethacin; Integrins; Lymphoma; M

2000